Global Newborn Screening Market - Industry Trends and Forecast to 2026

1 INTRODUCTION 22

1.1 OBJECTIVES OF THE STUDY 22

1.2 MARKET DEFINITION 22

1.3 OVERVIEW OF GLOBAL NEWBORN SCREENING MARKET 22

1.4 LIMITATIONS 23

1.5 CURRENCY AND PRICING 23

1.6 MARKETS COVERED 24

2 MARKET SEGMENTATION 26

2.1 MARKETS COVERED 26

2.2 GEOGRAPHICAL SCOPE 27

2.3 YEARS CONSIDERED FOR THE STUDY 28

2.4 DBMR TRIPOD DATA VALIDATION MODEL 29

2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 32

2.6 SECONDARY SOURCES 33

2.7 ASSUMPTIONS 33

3 MARKET OVERVIEW 34

3.1 DRIVERS 36

3.1.1 RISING PREVALENCE OF NEWBORN SCREENING 36

3.1.2 GROWTH IN NEONATAL DISEASES 38

3.1.3 INCREASED GOVERNMENT INITIATIVES 40

3.1.4 TECHNOLOGICAL ADVANCEMENTS IN SCREENING 41

3.2 RESTRAINTS 42

3.2.1 STRINGENT REGULATORY POLICIES 42

3.2.2 HIGH COST OF AUTOMATED DEVICES 43

3.3 OPPORTUNITIES 44

3.3.1 NEXT-GENERATION SEQUENCING TECHNOLOGY FOR NEWBORN SCREENING 44

3.3.2 EMERGING MARKET 44

3.4 CHALLENGES 46

3.4.1 SOCIO ECONOMIC BARRIERS 46

3.4.2 LACK OF SKILLED PROFESSIONALS 46

4 EXECUTIVE SUMMARY 47

5 PREMIUM INSIGHTS 50

6 GLOBAL NEWBORN SCREENING MARKET, BY TEST TYPE 53

6.1 OVERVIEW 54

6.2 DRIED BLOOD SPOT TEST 55

6.3 HEARING SCREEN TEST 56

6.4 CRITICAL CONGENITAL HEART DISEASES (CCHD) TEST 57

7 GLOBAL NEWBORN SCREENING MARKET, BY PRODUCT TYPE 58

7.1 OVERVIEW 59

7.2 INSTRUMENTS 60

7.2.1 NEWBORN DISORDER SCREENING INSTRUMENTS 60

7.2.2 NEWBORN HEARING SCREENING INSTRUMENTS 61

7.2.3 PULSE OXIMETER 61

7.3 REAGENTS AND ASSAY KITS 61

8 GLOBAL NEWBORN SCREENING MARKET, BY TECHNOLOGY 62

8.1 OVERVIEW 63

8.2 TANDEM MASS SPECTROMETRY 64

8.3 HEARING SCREEN TECHNOLOGY 65

8.4 PULSE OXIMETRY SCREENING TECHNOLOGY 66

8.5 IMMUNOASSAYS AND ENZYMATIC ASSAYS 66

8.6 ELECTROPHORESIS 67

8.7 DNA-BASED ASSAYS 67

9 GLOBAL NEWBORN SCREENING MARKET, BY DISEASE TYPE 68

9.1 OVERVIEW 69

9.2 CRITICAL CONGENITAL HEART DISEASES 70

9.3 NEWBORN HEARING LOSS 71

9.4 SICKLE CELL DISEASE 72

9.5 PHENYLKETONURIA (PKU) 73

9.6 CYSTIC FIBROSIS (CF) 74

9.7 MAPLE SYRUP URINE DISEASE 75

9.8 OTHERS 76

10 GLOBAL NEWBORN SCREENING MARKET, BY END USER 77

10.1 OVERVIEW 78

10.2 HOSPITAL 79

10.3 PEDIATRIC CLINICS 79

10.4 CLINICS 80

11 GLOBAL NEWBORN SCREENING MARKET, BY GEOGRAPHY 81

11.1 OVERVIEW 82

11.2 NORTH AMERICA 87

11.2.1 U.S. 92

11.2.2 CANADA 94

11.2.3 MEXICO 96

11.3 EUROPE 98

11.3.1 GERMANY 104

11.3.2 FRANCE 106

11.3.3 U.K. 108

11.3.4 SPAIN 110

11.3.5 ITALY 112

11.3.6 SWITZERLAND 114

11.3.7 NETHERLANDS 116

11.3.8 RUSSIA 118

11.3.9 TURKEY 120

11.3.10 BELGIUM 122

11.3.11 REST OF EUROPE 124

11.4 ASIA-PACIFIC 125

11.4.1 JAPAN 131

11.4.2 CHINA 133

11.4.3 INDIA 135

11.4.4 SOUTH KOREA 137

11.4.5 AUSTRALIA 139

11.4.6 SINGAPORE 141

11.4.7 THAILAND 143

11.4.8 MALAYSIA 145

11.4.9 INDONESIA 147

11.4.10 PHILIPPINES 149

11.4.11 VIETNAM 151

11.4.12 REST OF ASIA-PACIFIC 153

11.5 SOUTH AMERICA 154

11.5.1 BRAZIL 160

11.5.2 REST OF SOUTH AMERICA 162

11.6 MIDDILE EAST AND AFRICA 163

11.6.1 SOUTH AFRICA 168

11.6.2 REST OF MIDDLE EAST & AFRICA 170

12 GLOBAL NEWBORN SCREENING MARKET, COMPANY LANDSCAPE 171

12.1 COMPANY SHARE ANALYSIS: GLOBAL 171

12.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 172

12.3 COMPANY SHARE ANALYSIS: EUROPE 173

12.4 COMPANY SHARE ANALYSIS: ASIA PACIFIC 174

13 COMPANY PROFILES 175

13.1 PERKINELMER INC. 175

13.1.1 COMPANY SNAPSHOT 175

13.1.2 REVENUE ANALYSIS 175

13.1.3 PRODUCT PORTFOLIO 176

13.1.4 RECENT DEVELOPMENTS 180

13.2 NATUS MEDICAL INCORPORATED 181

13.2.1 COMPANY SNAPSHOT 181

13.2.2 REVENUE ANALYSIS 181

13.2.3 PRODUCT PORTFOLIO 182

13.2.4 RECENT DEVELOPMENTS 182

13.3 TRIVITRON HEALTHCARE 183

13.3.1 COMPANY SNAPSHOT 183

13.3.2 PRODUCT PORTFOLIO 183

13.3.3 RECENT DEVELOPMENTS 184

13.4 BAEBIES, INC. 185

13.4.1 COMPANY SNAPSHOT 185

13.4.2 PRODUCT PORTFOLIO 185

13.4.3 RECENT DEVELOPMENTS 185

13.5 BIO-RAD LABORATORIES, INC. 186

13.5.1 COMPANY SNAPSHOT 186

13.5.2 REVENUE ANALYSIS 186

13.5.3 PRODUCT PORTFOLIO 187

13.5.4 RECENT DEVELOPMENT 187

13.6 DANAHER 188

13.6.1 COMPANY SNAPSHOT 188

13.6.2 REVENUE ANALYSIS 188

13.6.3 PRODUCT PORTFOLIO 189

13.6.4 RECENT DEVELOPMENT 189

13.7 HILL-ROM SERVICES INC. 190

13.7.1 COMPANY SNAPSHOT 190

13.7.2 REVENUE ANALYSIS 190

13.7.3 PRODUCT PORTFOLIO 191

13.7.4 RECENT DEVELOPMENT 191

13.8 INTELLIGENT HEARING SYSTEMS 192

13.8.1 COMPANY SNAPSHOT 192

13.8.2 PRODUCT PORTFOLIO 192

13.8.3 RECENT DEVELOPMENT 192

13.9 INTERACOUSTICS A/S 193

13.9.1 COMPANY SNAPSHOT 193

13.9.2 PRODUCT PORTFOLIO 193

13.9.3 RECENT DEVELOPMENTS 194

13.10 MASIMO 195

13.10.1 COMPANY SNAPSHOT 195

13.10.2 REVENUE ANALYSIS 195

13.10.3 PRODUCT PORTFOLIO 196

13.10.4 RECENT DEVELOPMENT 196

13.11 MEDTRONIC 197

13.11.1 COMPANY SNAPSHOT 197

13.11.2 REVENUE ANALYSIS 197

13.11.3 PRODUCT PORTFOLIO 198

13.11.4 RECENT DEVELOPMENT 198

13.12 OTODYNAMICS LTD 199

13.12.1 COMPANY SNAPSHOT 199

13.12.2 PRODUCT PORTFOLIO 199

13.12.3 RECENT DEVELOPMENTS 200

13.13 VIVASONIC INC. 201

13.13.1 COMPANY SNAPSHOT 201

13.13.2 PRODUCT PORTFOLIO 201

13.13.3 RECENT DEVELOPMENTS 201

13.14 ZENTECH S.A. 202

13.14.1 COMPANY SNAPSHOT 202

13.14.2 PRODUCT PORTFOLIO 202

13.14.3 RECENT DEVELOPMENTS 203

14 QUESTIONNAIRE 204

15 RELATED REPORTS 207

UU

TABLE 1 NEWBORN SCREENING PROGRAM (2015 & 2016) IN THE U.S. 36

TABLE 2 NEONATAL MORTALITY RATE (DEATHS PER 1,000 LIVE BIRTHS), IN BETWEEN 2015 -2018 38

TABLE 3 PREVALENCE OF DISORDERS AMONG FILIPINO NEWBORNS (1996-2016) 38

TABLE 4 NUMBER OF BIRTHS IN NORTHERN HEMISPHERE (2018) 39

TABLE 5 PREVALENCE OF DISORDERS AMONG NORTHERN HEMISPHERE (2018) 39

TABLE 6 COSTS OF NEXT GENENARATION SEQUENCING DEVICES (USD MILLION) 43

TABLE 7 HEALTHCARE EXPENDITURE IN ASIA PACIFIC (USD MILLION) 44

TABLE 8 COMPARISON OF THE ECONOMIC PROSPERITY AND ANNUAL PERCENTAGE OF NEWBORN BABIES SCREENED IN SELECTED DEVELOPING NATIONS 45

TABLE 9 GLOBAL NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION) 55

TABLE 10 GLOBAL DRIED BLOOD SPOT TEST IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION) 55

TABLE 11 GLOBAL HEARING SCREEN TEST IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION) 56

TABLE 12 GLOBAL CRITICAL CONGENITAL HEART DISEASES TEST IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION) 57

TABLE 13 GLOBAL NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 59

TABLE 14 GLOBAL PRODUCT IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION) 60

TABLE 15 GLOBAL INSTRUMENTS IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 60

TABLE 16 GLOBAL REAGENTS AND ASSAY KITS IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION) 61

TABLE 17 GLOBAL NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 63

TABLE 18 GLOBAL TANDEM MASS SPECTROMETRY IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION) 64

TABLE 19 GLOBAL HEARING SCREEN TECHNOLOGY IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION) 65

TABLE 20 GLOBAL PULSE OXIMETRY SCREENING TECHNOLOGY IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION) 66

TABLE 21 GLOBAL IMMUNOASSAYS AND ENZYMATIC ASSAYS IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION) 66

TABLE 22 GLOBAL ELECTROPHORESIS IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION) 67

TABLE 23 GLOBAL DNA-BASED ASSAYS IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION) 67

TABLE 24 GLOBAL NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION) 69

TABLE 25 GLOBAL CRITICAL CONGENITAL HEART DISEASES IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION) 70

TABLE 26 GLOBAL NEWBORN HEARING LOSS IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION) 71

TABLE 27 GLOBAL SICKLE CELL DISEASE IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION) 72

TABLE 28 GLOBAL PHENYLKETONURIA IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION) 73

TABLE 29 GLOBAL CYSTIC FIBROSIS IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION) 74

TABLE 30 GLOBAL MAPLE SYRUP URINE DISEASE IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION) 75

TABLE 31 GLOBAL OTHERS IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION) 76

TABLE 32 GLOBAL NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION) 78

TABLE 33 GLOBAL HOSPITAL IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION) 79

TABLE 34 GLOBAL PEDIATRIC CLINICS IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION) 79

TABLE 35 GLOBAL CLINICS IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION) 80

TABLE 36 GLOBAL NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION) 86

TABLE 37 NORTH AMERICA NEWBORN SCREENING MARKET, BY COUNTRY, 2017-2026 (USD MILLION) 90

TABLE 38 NORTH AMERICA NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION) 90

TABLE 39 NORTH AMERICA NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 90

TABLE 40 NORTH AMERICA INSTRUMENT IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 90

TABLE 41 NORTH AMERICA NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 91

TABLE 42 NORTH AMERICA NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION) 91

TABLE 43 NORTH AMERICA NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION) 91

TABLE 44 U.S. NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION) 92

TABLE 45 U.S. NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 92

TABLE 46 U.S. INSTRUMENT IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 92

TABLE 47 U.S. NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 93

TABLE 48 U.S. NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION) 93

TABLE 49 U.S. NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION) 93

TABLE 50 CANADA NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION) 94

TABLE 51 CANADA NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 94

TABLE 52 CANADA INSTRUMENT IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 94

TABLE 53 CANADA NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 95

TABLE 54 CANADA NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION) 95

TABLE 55 CANADA NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION) 95

TABLE 56 MEXICO NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION) 96

TABLE 57 MEXICO NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 96

TABLE 58 MEXICO INSTRUMENT IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 96

TABLE 59 MEXICO NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 97

TABLE 60 MEXICO NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION) 97

TABLE 61 MEXICO NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION) 97

TABLE 62 EUROPE NEWBORN SCREENING MARKET, BY COUNTRY, 2017-2026 (USD MILLION) 101

TABLE 63 EUROPE NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION) 101

TABLE 64 EUROPE NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 101

TABLE 65 EUROPE INSTRUMENT IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 102

TABLE 66 EUROPE NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 102

TABLE 67 EUROPE NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION) 102

TABLE 68 EUROPE NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION) 103

TABLE 69 GERMANY NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION) 104

TABLE 70 GERMANY NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 104

TABLE 71 GERMANY INSTRUMENT IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 104

TABLE 72 GERMANY NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 105

TABLE 73 GERMANY NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION) 105

TABLE 74 GERMANY NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION) 105

TABLE 75 FRANCE NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION) 106

TABLE 76 FRANCE NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 106

TABLE 77 FRANCE INSTRUMENT IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 106

TABLE 78 FRANCE NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 107

TABLE 79 FRANCE NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION) 107

TABLE 80 FRANCE NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION) 107

TABLE 81 U.K. NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION) 108

TABLE 82 U.K. NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 108

TABLE 83 U.K. INSTRUMENT IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 108

TABLE 84 U.K. NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 109

TABLE 85 U.K. NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION) 109

TABLE 86 U.K. NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION) 109

TABLE 87 SPAIN NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION) 110

TABLE 88 SPAIN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 110

TABLE 89 SPAIN INSTRUMENT IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 110

TABLE 90 SPAIN NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 111

TABLE 91 SPAIN NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION) 111

TABLE 92 SPAIN NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION) 111

TABLE 93 ITALY NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION) 112

TABLE 94 ITALY NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 112

TABLE 95 ITALY INSTRUMENTS IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 112

TABLE 96 ITALY NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 113

TABLE 97 ITALY NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION) 113

TABLE 98 ITALY NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION) 113

TABLE 99 SWITZERLAND NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION) 114

TABLE 100 SWITZERLAND NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 114

TABLE 101 SWITZERLAND INSTRUMENTS IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 114

TABLE 102 SWITZERLAND NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 115

TABLE 103 SWITZERLAND NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION) 115

TABLE 104 SWITZERLAND NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION) 115

TABLE 105 NETHERLANDS NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION) 116

TABLE 106 NETHERLANDS NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 116

TABLE 107 NETHERLANDS INSTRUMENTS IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 116

TABLE 108 NETHERLANDS NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 117

TABLE 109 NETHERLANDS NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION) 117

TABLE 110 NETHERLANDS NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION) 117

TABLE 111 RUSSIA NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION) 118

TABLE 112 RUSSIA NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 118

TABLE 113 RUSSIA INSTRUMENTS IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 118

TABLE 114 RUSSIA NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 119

TABLE 115 RUSSIA NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION) 119

TABLE 116 RUSSIA NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION) 119

TABLE 117 TURKEY NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION) 120

TABLE 118 TURKEY NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 120

TABLE 119 TURKEY INSTRUMENTS IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 120

TABLE 120 TURKEY NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 121

TABLE 121 TURKEY NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION) 121

TABLE 122 TURKEY NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION) 121

TABLE 123 BELGIUM NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION) 122

TABLE 124 BELGIUM NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 122

TABLE 125 BELGIUM INSTRUMENTS IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 122

TABLE 126 BELGIUM NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 123

TABLE 127 BELGIUM NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION) 123

TABLE 128 BELGIUM NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION) 123

TABLE 129 REST OF EUROPE NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION) 124

TABLE 130 ASIA-PACIFIC NEWBORN SCREENING MARKET, BY COUNTRY, 2017-2026 (USD MILLION) 128

TABLE 131 ASIA-PACIFIC NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION) 128

TABLE 132 ASIA-PACIFIC NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 128

TABLE 133 ASIA-PACIFIC INSTRUMENT IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 129

TABLE 134 ASIA-PACIFIC NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 129

TABLE 135 ASIA-PACIFIC NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION) 129

TABLE 136 ASIA-PACIFIC NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION) 130

TABLE 137 JAPAN NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION) 131

TABLE 138 JAPAN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 131

TABLE 139 JAPAN INSTRUMENT IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 131

TABLE 140 JAPAN NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 132

TABLE 141 JAPAN NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION) 132

TABLE 142 JAPAN NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION) 132

TABLE 143 CHINA NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION) 133

TABLE 144 CHINA NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 133

TABLE 145 CHINA INSTRUMENT IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 133

TABLE 146 CHINA NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 134

TABLE 147 CHINA NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION) 134

TABLE 148 CHINA NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION) 134

TABLE 149 INDIA NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION) 135

TABLE 150 INDIA NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 135

TABLE 151 INDIA INSTRUMENT IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 135

TABLE 152 INDIA NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 136

TABLE 153 INDIA NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION) 136

TABLE 154 INDIA NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION) 136

TABLE 155 SOUTH KOREA NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION) 137

TABLE 156 SOUTH KOREA NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 137

TABLE 157 SOUTH KOREA INSTRUMENT IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 137

TABLE 158 SOUTH KOREA NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 138

TABLE 159 SOUTH KOREA NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION) 138

TABLE 160 SOUTH KOREA NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION) 138

TABLE 161 AUSTRALIA NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION) 139

TABLE 162 AUSTRALIA NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 139

TABLE 163 AUSTRALIA INSTRUMENT IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 139

TABLE 164 AUSTRALIA NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 140

TABLE 165 AUSTRALIA NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION) 140

TABLE 166 AUSTRALIA NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION) 140

TABLE 167 SINGAPORE NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION) 141

TABLE 168 SINGAPORE NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 141

TABLE 169 SINGAPORE INSTRUMENT IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 141

TABLE 170 SINGAPORE NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 142

TABLE 171 SINGAPORE NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION) 142

TABLE 172 SINGAPORE NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION) 142

TABLE 173 THAILAND NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION) 143

TABLE 174 THAILAND NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 143

TABLE 175 THAILAND INSTRUMENT IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 143

TABLE 176 THAILAND NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 144

TABLE 177 THAILAND NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION) 144

TABLE 178 THAILAND NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION) 144

TABLE 179 MALAYSIA NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION) 145

TABLE 180 MALAYSIA NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 145

TABLE 181 MALAYSIA INSTRUMENT IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 145

TABLE 182 MALAYSIA NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 146

TABLE 183 MALAYSIA NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION) 146

TABLE 184 MALAYSIA NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION) 146

TABLE 185 INDONESIA NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION) 147

TABLE 186 INDONESIA NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 147

TABLE 187 INDONESIA INSTRUMENT IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 147

TABLE 188 INDONESIA NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 148

TABLE 189 INDONESIA NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION) 148

TABLE 190 INDONESIA NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION) 148

TABLE 191 PHILIPPINES NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION) 149

TABLE 192 PHILIPPINES NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 149

TABLE 193 PHILIPPINES INSTRUMENT IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 149

TABLE 194 PHILIPPINES NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 150

TABLE 195 PHILIPPINES NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION) 150

TABLE 196 PHILIPPINES NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION) 150

TABLE 197 VIETNAM NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION) 151

TABLE 198 VIETNAM NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 151

TABLE 199 VIETNAM INSTRUMENT IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 151

TABLE 200 VIETNAM NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 152

TABLE 201 VIETNAM NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION) 152

TABLE 202 VIETNAM NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION) 152

TABLE 203 REST OF ASIA-PACIFIC NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION) 153

TABLE 204 SOUTH AMERICA NEWBORN SCREENING MARKET, BY COUNTRY, 2017-2026 (USD MILLION) 157

TABLE 205 SOUTH AMERICA NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION) 157

TABLE 206 SOUTH AMERICA NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 157

TABLE 207 SOUTH AMERICA INSTRUMENT IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 157

TABLE 208 SOUTH AMERICA NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 158

TABLE 209 SOUTH AMERICA NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION) 158

TABLE 210 SOUTH AMERICA NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION) 159

TABLE 211 BRAZIL NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION) 160

TABLE 212 BRAZIL NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 160

TABLE 213 BRAZIL INSTRUMENT IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 160

TABLE 214 BRAZIL NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 161

TABLE 215 BRAZIL NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION) 161

TABLE 216 BRAZIL NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION) 161

TABLE 217 REST OF SOUTH AMERICA NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION) 162

TABLE 218 MIDDLE EAST AND AFRICA NEWBORN SCREENING MARKET, BY COUNTRY, 2017-2026 (USD MILLION) 166

TABLE 219 MIDDLE EAST AND AFRICA NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION) 166

TABLE 220 MIDDLE EAST AND AFRICA NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 166

TABLE 221 MIDDLE EAST AND AFRICA INSTRUMENTS IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 166

TABLE 222 MIDDLE EAST AND AFRICA NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 167

TABLE 223 MIDDLE EAST AND AFRICA NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION) 167

TABLE 224 MIDDLE EAST AND AFRICA NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION) 167

TABLE 225 SOUTH AFRICA NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION) 168

TABLE 226 SOUTH AFRICA NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 168

TABLE 227 SOUTH AFRICA INSTRUMENTS IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION) 168

TABLE 228 SOUTH AFRICA NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 169

TABLE 229 SOUTH AFRICA NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION) 169

TABLE 230 SOUTH AFRICA NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION) 169

TABLE 231 REST OF MIDDLE EAST & AFRICA NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION) 170